sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> diabetic nephropathy market

report

Diabetic Nephropathy Market, by Treatment Types (Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Diuretics, Calcium Channel Blockers, Renin Inhibitors, Connective Tissue Growth Factor Inhibitors, Antioxidant Inflammation Modulators, Endothelin A Receptor Antagonists, Monocyte Chemoattractant Proteins Inhibitors, G Protein-Coupled Receptors) - Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC216 January 2017 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the diabetic nephropathy market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the diabetic nephropathy market. The scope of this report covers the diabetic nephropathy market by its major segments, which include the treatment types and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The growing prevalence of diabetes and the increasing research and development by the pharmaceutical companies are some of the factors propelling the growth of the diabetic nephropathy market.
  • The increasing awareness and growing use of combination therapy are likely to boost the market for diabetic nephropathy during the forecast period.
  • However, strict regulatory norms are some of the major hindrances for the growth of the global diabetic nephropathy market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s diabetic nephropathy market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the diabetic nephropathy market by the following segments:

  • Diabetic Nephropathy Market, by Treatment Types
    • Angiotensin Converting Enzyme Inhibitors
    • Angiotensin Receptor Blockers
    • Diuretics
    • Calcium Channel Blockers
    • Renin Inhibitors
    • Connective Tissue Growth Factor Inhibitors
    • Antioxidant Inflammation Modulator
    • Endothelin A Receptor Antagonist
    • Monocyte Chemoattractant Proteins Inhibitor
    • G Protein-Coupled Receptors

KEY MARKET PLAYERS

Key players in the diabetic nephropathy market include:

  • Bayer AG
  • AbbVie Inc.
  • Merck
  • Genkyotex S.A.
  • ChemoCentryx, Inc.
  • Mesoblast Ltd.
  • Novartis AG
  • Mallinckrodt. 
  • Sanofi 
  • Eli Lilly and Company

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Middle East & Africa
    • Latin America

Diabetic Nephropathy Market

TRENDING RELATED REPORT

Diabetes Care Devices Market, by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), End-users (Hospitals, Homecare, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022​


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Analysis
    3. Ecosystem Analysis
  5. DIABETIC NEPHROPATHY MARKET, BY TREATMENT TYPES
    1. Segment Share
    2. Treatment Types
      1. Angiotensin Converting Enzyme Inhibitors
      2. Angiotensin Receptor Blockers
      3. Diuretics
      4. Calcium Channel Blockers
      5. Renin Inhibitors
      6. Connective Tissue Growth Factor Inhibitors
      7. Antioxidant Inflammation Modulator
      8. Endothelin A Receptor Antagonist
      9. Monocyte Chemoattractant Proteins Inhibitor
      10. G Protein-Coupled Receptors
  6. DIABETIC NEPHROPATHY MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Treatment Types
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Treatment Types
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Treatment Types
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East and Africa
      2. By Treatment Types
  7. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2015
    2. Key Innovators
  8. KEY MARKET PLAYERS
    1. Bayer AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. AbbVie Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Merck
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Genkyotex S.A.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. ChemoCentryx, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Mesoblast Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Mallinckrodt. 
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Sanofi 
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10.  Eli Lilly and Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
  9. SCALAR 360 DEGREE MARKET PERSPECTIVE
  10. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us